Dr. Kavanaugh-McHugh is Director of Fetal Cardiology at Monroe Carell Jr. Children's Hospital at Vanderbilt. Her research efforts have focused on the understanding and treatment of fetal congenital heart disease and fetal arrhythmias both in projects at Vanderbilt and as a collaborator in multicenter research projects. The Fetal Cardiology Team is an active participant in multicenter studies through the Fetal Heart Society and contributes fetal data to the Pediatric Cardiac Critical Care Consortium (PC4). In addition, Dr. Kavanaugh-McHugh has been involved in quality improvement efforts through the American College of Cardiology ACPC Non-Invasive Imaging Quality Metric Team and the National Pediatric Cardiology Quality Improvement Collaborative, which works to improve care and outcomes for babies with HLHS.

>> View Publications on PubMed

>> View Publications on PubMed

>> Learn more about the Antimicrobial Stewardship Program

Dr. Kannankeril is a pediatric electrophysiologist with a Master of Science in Clinical Investigation (MSCI) whose research has been NIH funded for over 15 years. He is Co-Director of the Center for Pediatric Precision Medicine at Vanderbilt, with faculty appointments in both the Vanderbilt Genetics Institute (VGI) and the Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART). His research program investigates genetic variants and their contribution to cardiovascular disease and clinical outcomes (Personalized Medicine). He is contact PI for the NIH-funded Vanderbilt Integrated Center of Excellence in Maternal and Pediatric Precision Therapeutics (VICE-MPRINT), one of only 2 funded Centers of Excellence in the nation. He has served on the research committee for the Heart Rhythm Society and as Vice President for Research for the Pediatric & Congenital Electrophysiology Society.

>> View Publications on PubMed

Dr. Jones' research interests are in cancer-related kidney disease and cardiovascular alterations among children with hypertension and/or chronic kidney disease, including evaluation of renal function in children with cancer to allow accurate dosing of chemotherapy, acute kidney injury in children with cancer, late effects of cancer and cancer therapy, and left ventricular remodeling and arterial alterations as they relate to ambulatory blood pressure patterns in children with hypertension.